BioMarin Plans FDA Submission After Positive VOXZOGO Hypochondroplasia Trial
BioMarin’s VOXZOGO improved growth in children with hypochondroplasia, showing strong trial results and good safety.
/ 1655 items
#XY↓
Lilly Buys Engage Bio for $202M to Unlock Safer, Repeatable DNA Therapies
Eli Lilly buys Engage Bio for up to $202M to boost safer gene therapy using non-viral DNA delivery technology.
Jupiter Neurosciences Signs $100M Deal for Next-Gen MDMA Therapy
Jupiter secured $100M rights to sell safer MDMA drug ALA-002 in the US, targeting mental health treatment growth.
FDA Approves Guardant360 Liquid CDx: The Largest Blood Test for Cancer Just Got 100x Smarter
FDA approved Guardant’s new blood test detects cancer DNA and signals from one sample for faster, smarter treatment decisions.
CODX Prepares Fast Ebola Test as WHO Declares International Emergency
Co-Diagnostics readies Ebola test as outbreak grows; aims for fast detection, but test still awaiting regulatory approval.
Cullinan Therapeutics Receives FDA Orphan Status for Promising AML Therapy CLN-049
FDA gave orphan status to CLN-049 for AML. It uses T cells to attack cancer cells and is in early clinical trials.